Physician profile
Jonathan Eric Botstein
NPI 1336385616
$4,966.63
in general payments reported to CMS, 2019-2025
21 companies · $88.49 in 2025
The $88.49 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $993 · 2020: $232 · 2021: $578 · 2022: $1,885 · 2023: $729 · 2024: $463 · 2025: $88.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,280.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,279.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,095.56 | 2021-2025 | Osteocool Rf Ablation System |
| Medtronic USA, INC. | $949.72 | 2019-2020 | |
| Trisalus Life Sciences, INC. | $238.81 | 2023-2024 | Trinav Infusion System |
| Siemens Medical Solutions USA, INC. | $174.94 | 2023 | Magnetom Sola, System Somatom Drive, Multitom Rax |
| Sirtex Medical INC | $157.29 | 2019-2020 | |
| Inari Medical, INC. | $54.46 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Cardiva Medical, INC. | $49.01 | 2022 | |
| Tersera Therapeutics LLC | $28.78 | 2019 | |
| Kyowa Kirin, INC. | $24.44 | 2019 | |
| W. L. Gore & Associates, INC. | $20.05 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $19.52 | 2019 | |
| Macrogenics, INC. | $18.68 | 2022 | |
| Incyte Corporation | $18.13 | 2022 | |
| Puma Biotechnology, INC. | $16.31 | 2020 | |
| Angiodynamics, INC. | $16.14 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $15.73 | 2019 | |
| Pharmacosmos Therapeutics INC. | $14.79 | 2023 | Monoferric |
| Genentech USA, INC. | $14.31 | 2023 | Tecentriq |
| Adc Therapeutics America, INC. | $14.16 | 2022 | |
| Balt USA, LLC | $13.42 | 2024 | Prestige Coil System |
| Takeda Pharmaceuticals U.S.A., INC. | $12.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Botstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.